INVIVO THERAPEUTICS HOLDINGS CORP. Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Invivo Therapeutics Holdings Corp. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2022.
  • Invivo Therapeutics Holdings Corp. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $38K, a 2.7% increase year-over-year.
  • Invivo Therapeutics Holdings Corp. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $187K, a 3.11% decline year-over-year.
  • Invivo Therapeutics Holdings Corp. annual Share-based Payment Arrangement, Expense for 2022 was $159K, a 49.5% decline from 2021.
  • Invivo Therapeutics Holdings Corp. annual Share-based Payment Arrangement, Expense for 2021 was $315K, a 46.5% increase from 2020.
  • Invivo Therapeutics Holdings Corp. annual Share-based Payment Arrangement, Expense for 2020 was $215K, a 19.8% decline from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $159K -$156K -49.5% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-01
2021 $315K +$100K +46.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-01
2020 $215K -$53K -19.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-07
2019 $268K -$350K -56.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 $618K -$3.48M -84.9% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-20
2017 $4.1M -$963K -19% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 $5.06M +$397K +8.51% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-12
2015 $4.67M +$1.94M +70.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 $2.73M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.